Request Demo
Last update 02 Jan 2025
Autologous CD20 Chimeric Antigen Receptor T-cells(Hebei Senlangbio Biotechnology)
Last update 02 Jan 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Autologous CD20 Chimeric Antigen Receptor T-cells(Hebei Senlangbio Biotechnology)NCT05618041
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
NCT05388695
To Observe the Long-term Efficacy and Safety of Dual-target Chimeric Antigen Receptor T Cells in the Treatment of Refractory Relapsed B Cell Hematologic Tumors
100 Clinical Results associated with Autologous CD20 Chimeric Antigen Receptor T-cells(Hebei Senlangbio Biotechnology)
Login to view more data
100 Translational Medicine associated with Autologous CD20 Chimeric Antigen Receptor T-cells(Hebei Senlangbio Biotechnology)
Login to view more data
100 Patents (Medical) associated with Autologous CD20 Chimeric Antigen Receptor T-cells(Hebei Senlangbio Biotechnology)
Login to view more data
100 Deals associated with Autologous CD20 Chimeric Antigen Receptor T-cells(Hebei Senlangbio Biotechnology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | CN | 08 Apr 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free